Vectorite Biomedical Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 10.669 million compared to TWD 12.216 million a year ago. Operating loss was TWD 33.437 million compared to TWD 37.455 million a year ago. Net loss was TWD 31.475 million compared to TWD 37.124 million a year ago. Basic loss per share was TWD 0.75 compared to TWD 0.88 a year ago.